CNTB
Connect Biopharma Holdings Ltd
NASDAQ: CNTB · HEALTHCARE · BIOTECHNOLOGY
$2.53
+5.42% today
Updated 2026-04-29
Market cap
$142.43M
P/E ratio
—
P/S ratio
2,225.53x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Connect Biopharma Holdings Ltd (CNTB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $26.03M | $64000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | -99.8% |
| Cost of revenue | — | — | — | — | $1.03M | $988000.00 | $660000.00 | — |
| Gross profit | — | — | — | — | $-1.03M | $-988000.00 | $26.03M | $64000.00 |
| Gross margin | — | — | — | — | — | — | 100.0% | 100.0% |
| R&D | — | $15.44M | $23.12M | $80.50M | $96.63M | $53.00M | $29.26M | $37.80M |
| SG&A | — | $1.41M | $7.31M | $19.01M | $20.81M | $16.05M | $19.23M | $20.34M |
| Operating income | — | $-15.99M | $-30.30M | $-98.11M | $-119.32M | $-69.06M | $-22.45M | $-58.07M |
| Operating margin | — | — | — | — | — | — | -86.2% | -90740.6% |
| EBITDA | — | $-24.78M | $-118.21M | $-201.36M | $-116.74M | $-68.34M | $-21.79M | $-57.37M |
| EBITDA margin | — | — | — | — | — | — | -83.7% | -89640.6% |
| EBIT | $-66.02M | $-24.90M | $-118.43M | $-201.99M | $-117.77M | $-69.06M | $-22.45M | $-58.07M |
| Interest expense | $0.00 | $7689.00 | $6433.00 | $6909.00 | $21032.00 | $23000.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | $-24.46M | $-119.37M | $-202.27M | $-118.09M | $-62.11M | $-15.63M | $-55.48M |
| Net income growth (YoY) | — | — | -387.9% | -69.4% | +41.6% | +47.4% | +74.8% | -255.0% |
| Profit margin | — | — | — | — | — | — | -60.0% | -86687.5% |